Nitrofurantoin's efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials
Anouk E. Muller(Erasmus MC), Angela Huttner(University Hospital of Geneva), Johan W. Mouton(Canisius-Wilhelmina Ziekenhuis), Stephan Harbarth(University Hospital of Geneva), Els M. Verhaegh(Elisabeth-TweeSteden Ziekenhuis)
Cited by 78
Related Papers
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
|Clinical Microbiology and Infection|2021|1k
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
Tissue concentrations: do we ever learn?
|Journal of Antimicrobial Chemotherapy|2007|337
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
|Intensive Care Medicine|2023|293
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
|The Lancet Infectious Diseases|2015|278